Accretive Health Inc. is a leading provider of revenue cycle management and physician advisory services to healthcare providers that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ACHI’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Accretive Health could be a solid choice for investors.
Current Quarter Estimates for ACHI
In the past 30 days, 1 estimate has gone higher for Accretive Health while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates rising from a loss of 5 cents a share 30 days ago, to a loss of 3 cents per share today, a move of 66.7%.
Current Year Estimates for ACHI
Meanwhile, Accretive Health’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, rising from a loss of 31 cents per share 30 days ago to a loss of 28 cents per share today, an increase of 10.7%.
Accretive Health Inc. Price and Consensus
Bottom Line
The stock has also started to move higher lately, adding 7.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>
Image: Bigstock
Can Accretive Health (ACHI) Run Higher on Strong Earnings Estimate Revisions?
Accretive Health Inc. is a leading provider of revenue cycle management and physician advisory services to healthcare providers that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ACHI’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Accretive Health could be a solid choice for investors.
Current Quarter Estimates for ACHI
In the past 30 days, 1 estimate has gone higher for Accretive Health while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates rising from a loss of 5 cents a share 30 days ago, to a loss of 3 cents per share today, a move of 66.7%.
Current Year Estimates for ACHI
Meanwhile, Accretive Health’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, rising from a loss of 31 cents per share 30 days ago to a loss of 28 cents per share today, an increase of 10.7%.
Accretive Health Inc. Price and Consensus
Accretive Health Inc. Price and Consensus | Accretive Health Inc. Quote
Bottom Line
The stock has also started to move higher lately, adding 7.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>